-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The recent safety signals issued by national and international pharmacovigilance regulatory agencies, as well as the increasing number of reports on cerebral venous sinus thrombosis (CVST) and rare site thrombosis combined with thrombocytopenia (TTS), indicate that TTS and SARS-based viral vectors- CoV vaccine injection related
diagnosis
Recently, a study published in Neurology tried to provide the latest data on the proportion of CVST patients who did not meet the diagnostic criteria of TTS in TTS patients and patients who had thromboembolism and thromboembolic events after being vaccinated with SARS-CoV-2 vaccine
- 69 studies entered qualitative analysis, of which 370 patients had CVST, and any thrombotic event in 4182 patients was related to SARS-CoV-2 vector vaccination
About half of TTS patients have CVST, and almost a third of TTS patients cannot survive
Literature source: https://n.
Leave a message here